Martin Midstream Partners And 3 Other Penny Stocks Insiders Are Buying
Martin Midstream Partners And 3 Other Penny Stocks Insiders Are Buying
US consumer prices are projected to rise 1.1% on the month in June following a much hotter-than-expected 1.0% increase in the previous month. Investors, meanwhile, focused on some notable insider trades.
繼前一個月1.0%的漲幅遠高於預期之後,美國消費者價格指數預計將在6月份上漲1.1%。與此同時,投資者關注的是一些值得注意的內幕交易。
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
當內部人士買賣股票時,這表明了他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易員可以在他們的整體投資或交易決策中考慮這一因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3
以下是最近幾筆值得注意的細價股內幕交易。有關更多信息,請查看Benzinga的內幕交易平臺。
Crexendo
Crexendo
- The Trade: Crexendo, Inc. (NASDAQ:CXDO) CEO Steven G Mihaylo acquired a total of 363 shares at an average price of $3.00. To acquire these shares, it cost around $1.09 thousand.
- What's Happening: The company's stock dropped around 34% over the previous six months.
- What Crexendo Does: Crexendo Inc is a provider of cloud communications, UCaaS, call center, collaboration services, and other cloud business services.
- 行業: Crexendo,Inc.納斯達克(Sequoia Capital:CXDO)首席執行官史蒂文·G·米哈伊洛以3.00美元的平均價格收購了總共363股。收購這些股份的成本約為109萬美元。
- 正在發生的事情:在過去的六個月裏,該公司的股價下跌了約34%。
- Crexendo的用途:Crexendo Inc.是雲通信、UCaaS、呼叫中心、協作服務和其他雲業務服務的提供商。
Panacea Life Sciences Holdings
萬能生命科學控股公司
- The Trade: Panacea Life Sciences Holdings, Inc. (OTC:PLSH) CEO Leslie Buttorff acquired a total of 7,700 shares at an average price of $0.28. The insider spent around $2.18 thousand to buy those shares.
- What's Happening: The company's shares jumped 150% over the previous month.
- What Panacea Life Sciences Does: Panacea Life Sciences Holdings Inc is engaged in the production of legal, trace THC, hemp-derived cannabinoid products for consumers and pets.
- 《貿易》: Panacea生命科學控股公司(場外交易代碼:PLSH)首席執行官萊斯利·巴托夫以0.28美元的平均價格收購了總計7700股股票。這位內部人士花了大約2.18萬美元購買了這些股票。
- 發生了什麼事?:該公司的股價比前一個月上漲了150%。
- 靈丹妙藥生命科學的作用:Panacea生命科學控股公司致力於為消費者和寵物生產合法的、微量的THC、大麻衍生的大麻素產品。
Delta Air Lines, Fastenal And 3 Stocks To Watch Heading Into Wednesday
達美航空、Fastenal和週三即將到來的3只值得關注的股票
Don't forget to check out our premarket coverage here .
別忘了在這裏查看我們的售前報道。
Reflect Scientific
反思科學性
- The Trade: Reflect Scientific, Inc. (OTC:RSCF) CEO, CFO Kim Boyce acquired a total of 50,000 shares at an average price of $0.10. To acquire these shares, it cost around $5 thousand.
- What's Happening: The company's shares have declined over 12% since the start of the year.
- What Reflect Scientific Does: Reflect Scientific Inc is engaged in the manufacture and distribution of innovative products targeted at the life science market.
- 《貿易》: Reflect Science公司(場外交易代碼:RSCF)首席執行官兼首席財務官Kim Boyce以0.10美元的平均價格收購了總計5萬股。收購這些股份的成本約為5000美元。
- 發生了什麼事?自今年年初以來,該公司的股價已經下跌了12%以上。
- 什麼反映了科學的作用Reflect Science Inc.:Reflect Science Inc.致力於製造和分銷針對生命科學市場的創新產品。
Martin Midstream Partners
Martin Midstream Partners
- The Trade: Martin Midstream Partners L.P. (NASDAQ:MMLP) President and CEO Robert D Bondurant acquired a total of 584.8873 shares at an average price of $3.78. The insider spent $2.21 thousand to buy those shares.
- What's Happening: Martin Midstream Partners is expected to release its financial results for the second quarter ended June 30, 2022 on July 20, 2022.
- What Martin Midstream Partners Does: Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region.
- 《貿易》: Martin Midstream Partners L.P.納斯達克股票代碼:MMLP)總裁和首席執行官羅伯特·D·邦杜蘭特以3.78美元的平均價格收購了總計584.8873股。這位內部人士花了22.1萬美元購買了這些股票。
- 發生了什麼事?:Martin Midstream Partners預計將於2022年7月20日發佈截至2022年6月30日的第二季度財務業績。
- Martin Midstream Partners是做什麼的:Martin Midstream Partners LP在美國墨西哥灣沿岸地區擁有一系列多樣化的業務。